Literature DB >> 29743789

Direct-Acting Antiviral Agents for HCV Infection.

Madhumita Premkumar1, Radha K Dhiman1.   

Abstract

Year:  2018        PMID： 29743789      PMCID： PMC5938327          DOI： 10.1016/j.jceh.2018.01.002

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  14 in total

1.  Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion-dependent thalassaemia and HCV genotype 1 or 4 infection.

Authors:  A Mangia; R Sarli; R Gamberini; A Piga; G Cenderello; V Piazzolla; R Santoro; V Caruso; A Quarta; R Ganga; M Copetti; G Forni
Journal:  Aliment Pharmacol Ther       Date:  2017-06-29       Impact factor: 8.171

2.  ANALYSIS OF POLYMORPHISMS IN THE INTERLEUKIN 18 GENE PROMOTOR (-137 G/C AND -607 C/A) IN PATIENTS INFECTED WITH HEPATITIS C VIRUS FROM THE BRAZILIAN AMAZON.

Authors:  Kemper Nunes dos Santos; Marcella Kelly Costa de Almeida; Amanda Alves Fecury; Carlos Araújo da Costa; Luísa Caricio Martins
Journal:  Arq Gastroenterol       Date:  2015 Jul-Sep

Review 3.  Tackling the Hepatitis C Disease Burden in Punjab, India.

Authors:  Radha K Dhiman; Sandeep Satsangi; Gagandeep S Grover; Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2016-09-07

4.  Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.

Authors:  David Saadoun; Stanislas Pol; Yasmina Ferfar; Laurent Alric; Christophe Hezode; Si Nafa Si Ahmed; Luc de Saint Martin; Cloé Comarmond; Anne Sophie Bouyer; Lucile Musset; Thierry Poynard; Matthieu Resche Rigon; Patrice Cacoub
Journal:  Gastroenterology       Date:  2017-03-10       Impact factor: 22.682

Review 5.  Direct-acting antivirals for chronic hepatitis C.

Authors:  Janus C Jakobsen; Emil Eik Nielsen; Joshua Feinberg; Kiran Kumar Katakam; Kristina Fobian; Goran Hauser; Goran Poropat; Snezana Djurisic; Karl Heinz Weiss; Milica Bjelakovic; Goran Bjelakovic; Sarah Louise Klingenberg; Jian Ping Liu; Dimitrinka Nikolova; Ronald L Koretz; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2017-06-06

6.  Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.

Authors:  Ping An; Chloe L Thio; Gregory D Kirk; Sharyne Donfield; James J Goedert; Cheryl A Winkler
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

7.  Generic Direct Acting Antivirals in Treatment of Chronic Hepatitis C Infection in Patients of Thalassemia Major.

Authors:  Aabha Nagral; Smita Sawant; Nishtha Nagral; Pathik Parikh; Priya Malde; Rashid Merchant
Journal:  J Clin Exp Hepatol       Date:  2017-08-23

Review 8.  Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?

Authors:  Madhumita Premkumar; Gagandeep S Grover; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2017-09-23

9.  Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.

Authors:  Rakesh Aggarwal; Qiushi Chen; Amit Goel; Nicole Seguy; Razia Pendse; Turgay Ayer; Jagpreet Chhatwal
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

10.  Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.

Authors:  Nezam Afdhal; K Rajender Reddy; David R Nelson; Eric Lawitz; Stuart C Gordon; Eugene Schiff; Ronald Nahass; Reem Ghalib; Norman Gitlin; Robert Herring; Jacob Lalezari; Ziad H Younes; Paul J Pockros; Adrian M Di Bisceglie; Sanjeev Arora; G Mani Subramanian; Yanni Zhu; Hadas Dvory-Sobol; Jenny C Yang; Phillip S Pang; William T Symonds; John G McHutchison; Andrew J Muir; Mark Sulkowski; Paul Kwo
Journal:  N Engl J Med       Date:  2014-04-11       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.